RxDoctor Payments Data

Laura Truax, PA

Physician Assistant · Phoenix, AZNPI 1730499609

Payments from drug & device makers

$7,349in general payments, 2019–2025

Across 423 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$822
  • Novo Nordisk$549
  • AbbVie$545
  • Medtronic$528
  • Abbott$498
  • Amgen$390
  • plus $4K from 41 others

What the payments were for

  • Food & beverage$7,337100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,349 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$49,066
Medicare patients
192
Services billed
629

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide209$341,058
TrulicityDulaglutide120$183,566
JardianceEmpagliflozin105$120,282
Tresiba Flextouch U-200Insulin Degludec48$101,949
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog41$76,928
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/728$41,996
JanuviaSitagliptin Phosphate33$39,149
Lantus SolostarInsulin Glargine,hum.Rec.Anlog209$38,448
MounjaroTirzepatide23$37,969
Soliqua 100-33Insulin Glargine/Lixisenatide44$37,695
Tresiba Flextouch U-100Insulin Degludec47$31,384
FarxigaDapagliflozin Propanediol24$30,747
Insulin Lispro Kwikpen U-100Insulin Lispro69$26,017
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog28$20,911
Humalog Kwikpen U-100Insulin Lispro43$16,138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$549$343,408221 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro$822$234,962216 claims
Boehringer IngelheimJardiance, Tradjenta$166$127,745117 claims
MerckJanuvia$15$39,14933 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$195$37,69544 claims
AstraZenecaFarxiga$127$30,74724 claims
AbbVieSynthroid$545$4,36540 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$296$2,469255 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →